United States Next-Generation Biologics Market Size, Share, Growth, and Industry Analysis, By Product Type (Antibody Drug Conjugates, Bispecific Antibodies, Fusion Protein Therapeutics, Monoclonal Antibody Fragments  ), By Disease Area (Oncology, Autoimmune and Inflammatory Disorders, Genetic Disorders , Infectious Diseases  ) and Forecast, 2026-2034

Table of Contents

1. Executive Summary
   1. Introduction
2. Market Introduction
   1. Market Definition
   2. Scope of the Study
   3. Market Structure
3. Research Methodology
   1. Primary Research
   2. Research Methodology
   3. Assumptions & Exclusions
   4. Secondary Data Sources
4. Market Factor Analysis
   1. Value Chain Analysis: United States Next-Generation Biologics Market
   2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
5. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
6. Recent Trends Analysis
7. Impact of COVID-19 on United States Next-Generation Biologics Market
   1. Pre and Post Covid -19 Market Scenario Analysis
   2. Market Recovery Timeline and Challenge
   3. Measures Taken by Top Players
8. Regulatory Landscape
9. United States Next-Generation Biologics Market, By Product Type
   1. Introduction
      1. Market Size and Forecast, By Product Type
   2. Antibody Drug Conjugates
      1. Market Size and Forecast, By Region
   3. Bispecific Antibodies 
      1. Market Size and Forecast, By Region
   4. Fusion Protein Therapeutics 
      1. Market Size and Forecast, By Region
   5. Monoclonal Antibody Fragments  
      1. Market Size and Forecast, By Region
   6. Engineered Cytokines 
      1. Market Size and Forecast, By Region
   7. Cell-Based Therapies  
      1. Market Size and Forecast, By Region
   8. Gene Therapies 
      1. Market Size and Forecast, By Region
   9. RNA-Based Biologics  
      1. Market Size and Forecast, By Region
   10. Nanobodies and Single-Domain Antibodies 
       1. Market Size and Forecast, By Region
   11. Others  
       1. Market Size and Forecast, By Region
10. United States Next-Generation Biologics Market, By Disease Area
    1. Introduction
       1. Market Size and Forecast, By Disease Area
    2. Oncology 
       1. Market Size and Forecast, By Region
    3. Autoimmune and Inflammatory Disorders 
       1. Market Size and Forecast, By Region
    4. Genetic Disorders  
       1. Market Size and Forecast, By Region
    5. Infectious Diseases  
       1. Market Size and Forecast, By Region
    6. Ophthalmic Diseases  
       1. Market Size and Forecast, By Region
    7. Neurological Disorders 
       1. Market Size and Forecast, By Region
    8. Others  
       1. Market Size and Forecast, By Region
11. United States Next-Generation Biologics Market, By Manufacturing Platform
    1. Introduction
       1. Market Size and Forecast, By Manufacturing Platform
    2. Mammalian Cell Culture  
       1. Market Size and Forecast, By Region
    3. Microbial Systems  
       1. Market Size and Forecast, By Region
    4. Cell-Free Expression Systems
       1. Market Size and Forecast, By Region
    5. Viral Vectors  
       1. Market Size and Forecast, By Region
    6. RNA Synthesis Platforms 
       1. Market Size and Forecast, By Region
    7. Others  
       1. Market Size and Forecast, By Region
12. United States Next-Generation Biologics Market, By Route of Administration
    1. Introduction
       1. Market Size and Forecast, By Route of Administration
    2. Intravenous  
       1. Market Size and Forecast, By Region
    3. Subcutaneous  
       1. Market Size and Forecast, By Region
    4. Intramuscular  
       1. Market Size and Forecast, By Region
    5. Intrathecal/Intraocular 
       1. Market Size and Forecast, By Region
    6. Others  
       1. Market Size and Forecast, By Region
13. United States Next-Generation Biologics Market, By Distribution Channel
    1. Introduction
       1. Market Size and Forecast, By Distribution Channel
    2. Hospital Pharmacies 
       1. Market Size and Forecast, By Region
    3. Specialty Pharmacies 
       1. Market Size and Forecast, By Region
    4. Retail Pharmacies 
       1. Market Size and Forecast, By Region
    5. Others  
       1. Market Size and Forecast, By Region
14. Regional Overview
    1. Introduction
       1. Market Size and Forecast
    2. United States
       1. Market Size and Forecast
          1. By Product Type
             1. Antibody Drug Conjugates
             2. Bispecific Antibodies 
             3. Fusion Protein Therapeutics 
             4. Monoclonal Antibody Fragments  
             5. Engineered Cytokines 
             6. Cell-Based Therapies  
             7. Gene Therapies 
             8. RNA-Based Biologics  
             9. Nanobodies and Single-Domain Antibodies 
             10. Others  
          2. By Disease Area
             1. Oncology 
             2. Autoimmune and Inflammatory Disorders 
             3. Genetic Disorders  
             4. Infectious Diseases  
             5. Ophthalmic Diseases  
             6. Neurological Disorders 
             7. Others  
          3. By Manufacturing Platform
             1. Mammalian Cell Culture  
             2. Microbial Systems  
             3. Cell-Free Expression Systems
             4. Viral Vectors  
             5. RNA Synthesis Platforms 
             6. Others  
          4. By Route of Administration
             1. Intravenous  
             2. Subcutaneous  
             3. Intramuscular  
             4. Intrathecal/Intraocular 
             5. Others  
          5. By Distribution Channel
             1. Hospital Pharmacies 
             2. Specialty Pharmacies 
             3. Retail Pharmacies 
             4. Others  
15. Competitive Landscape, 2025
    1. Introduction
    2. United States Next-Generation Biologics Market Share Analysis, 2025 (%)
       1. Market Share Analysis, 2025
       2. Competition Ranking, 2025
       3. Key Developments & Growth Strategies
          1. Merger & Acquisition
          2. Product Launch
          3. Expansion
       4. Consolidated SWOT Analysis of Key Players
16. Company Profile
    1. Amgen Inc.
       1. Business Overview
       2. Financial Data
       3. Key Product domains
       4. Recent Developments
    2. AbbVie Inc.
    3. Bristol Myers Squibb
    4. Merck & Co., Inc.
    5. Pfizer Inc.
    6. Johnson & Johnson
    7. Gilead Sciences, Inc.
    8. Regeneron Pharmaceuticals, Inc.
    9. Eli Lilly and Company
    10. Roche/Genentech
    11. AstraZeneca
    12. Novartis AG
    13. Moderna, Inc.
    14. BioMarin Pharmaceutical Inc.
    15. Vertex Pharmaceuticals Incorporated